Enrolled patients will be at high risk for recurrent heart-failure hospitalizations by virtue of having elevated N-terminal pro-B-type natriuretic peptide/BNP ( > @,@ pg/ml , or > @,@ pg/ml if atrial fibrillation is present ) and/or recent heart failure hospitalization .